home / stock / calt / calt news


CALT News and Press, Calliditas Therapeutics AB From 03/14/22

Stock Information

Company Name: Calliditas Therapeutics AB
Stock Symbol: CALT
Market: NASDAQ

Menu

CALT CALT Quote CALT Short CALT News CALT Articles CALT Message Board
Get CALT Alerts

News, Short Squeeze, Breakout and More Instantly...

CALT - Expansion of Everest Medicine's licence agreement to include South Korea

Expansion of Everest Medicine's licence agreement to include South Korea PR Newswire STOCKHOLM , March 14, 2022 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the company has expanded its l...

CALT - Everest Medicines Enters into Agreement with Calliditas Therapeutics, Expanding Territory License to Develop and Commercialize NEFECON in South Korea

Everest Medicines Enters into Agreement with Calliditas Therapeutics, Expanding Territory License to Develop and Commercialize NEFECON in South Korea PR Newswire Deal signals Company's latest efforts to further enhance its international commercial footprint SHA...

CALT - Year-End Report, 2021

Year-End Report, 2021 Calliditas became the first Company to receive accelerated approval in IgA Nephropathy. PR Newswire STOCKHOLM , Feb. 24, 2022 /PRNewswire/ -- "The accelerated approval of TARPEYO was for the indication of reduction of proteinuria, which ...

CALT - Calliditas randomizes first patient in phase 2b/3 study of setanaxib for liver disease

Calliditas Therapeutics (NASDAQ:CALT) said the first patient was randomized in a phase 2b/3 TRANSFORM study evaluating setanaxib in patients with primary biliary cholangitis (PBC). PBC is a disease in which the bile ducts in the liver are slowly destroyed. The 52-week global st...

CALT - First patient randomized in pivotal TRANSFORM study with setanaxib

First patient randomized in pivotal TRANSFORM study with setanaxib PR Newswire STOCKHOLM , Feb. 15, 2022 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the first patient has been randomized...

CALT - Calliditas Therapeutics Announces Commercial Availability and Initial Sales of TARPEYO(TM)

Calliditas Therapeutics Announces Commercial Availability and Initial Sales of TARPEYO™ PR Newswire STOCKHOLM , Jan. 28, 2022 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced the comme...

CALT - NVAX, BPMP and FSM among pre market gainers

Can-Fite BioPharma (NYSE:CANF) +71% liver cancer patient treated with can-Fite’s Namodenoson clears all cancer lesions under open label extension of phase II study. Society Pass Incorporated (NASDAQ:SOPA) +35% on being added to the Russell 2000 Index. Verso (NYSE:VRS) +3...

CALT - 5 Biotech Stocks For Your Late December 2021 Watchlist

5 Biotech Stocks To Check Out Before The End Of 2021 With the coronavirus pandemic kicking back into full swing, biotech stocks are once again at the forefront. For one thing, this part of the stock market today has and continues to work towards dealing with the pandemic. Now, as th...

CALT - BKKT, IRNT and PCSA among mid-day movers

Gainers: Adagio (NASDAQ:ADGI) +101%. Kaixin (NASDAQ:KXIN) +34%. Calliditas (NASDAQ:CALT) +25%. Euro Tech Holdings (NASDAQ:CLWT) +19%. Mechel (NYSE:MTL) +17%. Processa (NASDAQ:PCSA) +17%. Versus Systems (NASDAQ:VS) +17%. Assertio (NASDAQ:ASRT) +17%. Zai Lab (NASDAQ:ZLAB) +17%. Petros Pharmaceu...

CALT - FREY Stock: 7 Things to Know About FREYR Battery as Deal News Gives Shares a Charge Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips FREYR Battery (NYSE: FREY ) stock is soaring higher on Thursday thanks to a 31 GWh deal for its low-carbon battery cells. Source: asharkyu / Shutterstock.com Here’s everything investors in FREY stock n...

Previous 10 Next 10